Sunshine Biopharma (SBFM) Assets (2010 - 2026)
Sunshine Biopharma's Assets was $33.63 million in Q2 2026, up 5.2% from $31.97 million a year earlier and up 20.4% from the prior quarter.
Powered by 
Analysis
Sunshine Biopharma (SBFM) Assets (2010 - 2026) Analysis & Trends
At the end of FY2025, Assets at Sunshine Biopharma came in at $30.08 million, down 1.6% from FY2024.
- Assets shows a five-year compound annual growth rate of 95.8% (FY2020 to FY2025).
- In earlier years, Assets was $30.56 million in FY2024 (+11.8%), $27.35 million in FY2023 (-6.5%), $29.24 million in FY2022 and $2.2 million in FY2021 (+110.7%).
- The Q2 2026 figure marks the highest quarterly Assets since Q3 2022.
- Compared with a year earlier, Assets was higher in five of the last eight quarters, with growth averaging 3.1%.
- The best year-over-year quarter for Assets over five years was Q1 2022 (growth of 621.5%); the worst was Q2 2023 (a decline of 32.3%).
- Per Business Quant data, SBFM's Assets in the three quarters before Q2 2026 was $27.93 million (Q1 2026), $30.08 million (Q4 2025) and $31.49 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 201.06 Bn |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | 135.12 Bn |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | 129.80 Bn |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | 122.03 Bn |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | 115.83 Bn |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 95.64 Bn |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | 49.36 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 201.13 Bn |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | 27.42 Bn |
| 10 | Sunshine Biopharma | 1.08 Mn | -38.01 Mn | 2.43 Mn | 33.63 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 33.63 Mn |
| Mar 31, 2026 | 27.93 Mn |
| Dec 31, 2025 | 30.08 Mn |
| Sep 30, 2025 | 31.49 Mn |
| Jun 30, 2025 | 31.97 Mn |
| Mar 31, 2025 | 29.19 Mn |
| Dec 31, 2024 | 30.56 Mn |
| Sep 30, 2024 | 30.06 Mn |
| Jun 30, 2024 | 29.30 Mn |
| Mar 31, 2024 | 31.90 Mn |
| Dec 31, 2023 | 27.35 Mn |
| Sep 30, 2023 | 27.65 Mn |
| Jun 30, 2023 | 28.41 Mn |
| Mar 31, 2023 | 26.99 Mn |
| Dec 31, 2022 | 29.24 Mn |
| Sep 30, 2022 | 40.86 Mn |
| Jun 30, 2022 | 41.99 Mn |
| Mar 31, 2022 | 13.41 Mn |
| Dec 31, 2021 | 2.20 Mn |
| Sep 30, 2021 | 2.50 Mn |
API Access
Sunshine Biopharma Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=assets&ticker=SBFM&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "assets", "ticker": "SBFM", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=assets&ticker=SBFM&period=max&api_key=YOUR_API_KEY");
const data = await res.json();